Xeris Pharmaceuticals | XERS - 流动资产

金融业

USD

USD 383.53M

现金及等价物

USD 111.04M

USD 13.66M

USD 240.31M

USD 109.57M

USD 257.65M

USD 16.77M

USD 25.09M

377

EPS每股收益

USD 0.05

股本和储备

USD 13.69M

USD 72.15M

债务利息支出

USD 7.15M

USD 1.16M

USD 220.34M

USD 890.5M

USD 11.08M

USD 69.03M

USD 16.77M

普通股股本

USD 166.22M

2.45K

USD 11.08M

USD 85.81M

销售和管理费用

USD 42.64M

USD 68.67M

贸易债权人

USD 3.08M

应收帐款人

USD 51.05M

	流动资产	更改		日
Celltrion	KRW 5.54T		291.68B	2025-09
Cspc Pharmaceutical	CNY 22.25B		359.48M	2025-12
Deva Holding AS	TRY 9.13B		1.61B	2023-09
Dianthus Therapeutics	USD 1.12B		710.47M	2026-03
Divis Laboratories Ltd	INR 98.43B		2.38B	2025-09
Eli Lilly	USD 54.84B		794M	2026-03
Kangmei Pharma	CNY 7.03B		128.34M	2025-09
Knight Therapeutics	CAD 394.84M		5.86M	2025-12
Laboratorios Farma	EUR 509.33M		128.63M	2023-12
Malin Corporation	EUR 62.6M		26.7M	2024-12
Medical Developments International	AUD 33.75M		1.79M	2025-12
Nektar Therapeutics	USD 266.27M		15.09M	2025-12
Neuren Pharmaceuticals	AUD 332.23M		11.98M	2025-12
Organigram Holdings	CAD 256.54M		28.35M	2025-12
Ovoca Bio	EUR 1.56M		3.39M	2025-06
Pacira	USD 514.96M		33.01M	2026-03
Perrigo	USD 2.8B		81.8M	2025-12
Pharma Mar	EUR 273.45M		9.96M	2026-03
Qiagen NV	USD 2B		535.87M	2025-12
Sartorius	EUR 1.92B		157.2M	2026-03
Sino Biopharmaceutical	CNY 33.82B		9.13B	2025-06
Supernus Pharmaceuticals	USD 731.58M		87.4M	2026-03
Tilray	USD 729.32M		28.18M	2025-09
Zealand Pharma A/S	15.67B		950.94M	2025-12
Zz Pientze Pharmaceu	CNY 11.43B		728.95M	2026-03